Active, not recruitingPHASE2, PHASE3NCT05686356
A Pan-TB Regimen Targeting Host and Microbe
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Aurum Institute NPC
- Principal Investigator
- Professor Robert Wallis, MDThe Aurum Institute NPC
- Intervention
- Sutezolid(drug)
- Enrollment
- 352 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2023 – 2026
Study locations (8)
- Instituto Nacional de Saúde, Maputo, Mozambique
- Clinical HIV Research Unit, Durban, Durban, South Africa
- Clinical HIV Research Unit, Johannesburg, Gauteng, South Africa
- The Aurum Institute: Tembisa Clinical Research Centre, Tembisa, Gauteng, South Africa
- The Aurum Institute, Gavin J Churchyard Legacy Centre (Klerksdorp Clinical Research Centre), Klerksdorp, Klerksdorp, South Africa
- The Aurum Institute, Rustenburg Clinical Research Centre, Rustenburg, North West Provice, South Africa
- TASK Eden, George, Western Cape, South Africa
- NIMR-Mbeya Medical Research Centre, Mbeya, Tanzania
Collaborators
Ludwig-Maximilians - University of Munich · Stichting Katholieke Universiteit · Wits Health Consortium (Pty) Ltd · Instituto Nacional de Saúde, Mozambique · National Institute for Medical Research, Tanzania · University of Stellenbosch · Sequella, Inc. · Global Alliance for TB Drug Development
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05686356 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine